Michael Hadler
Cancer Genetics (United States)(US)Columbia University(US)
Publications by Year
Research Areas
RNA Interference and Gene Delivery, Acute Lymphoblastic Leukemia research, Immunotherapy and Immune Responses, Cancer-related gene regulation, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia(2012)525 cited
- → ETV6 mutations in early immature human T cell leukemias(2011)211 cited
- → The TLX1 oncogene drives aneuploidy in T cell transformation(2010)150 cited
- → Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia(2013)148 cited
- → Genetic loss of SH2B3 in acute lymphoblastic leukemia(2013)127 cited
- → Preclinical Analysis of the γ-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia(2012)106 cited
- → Lineage-specific splicing of a brain-enriched alternative exon promotes glioblastoma progression(2014)93 cited
- → Functional Separation of the Requirements for Establishment and Maintenance of Centromeric Heterochromatin(2007)77 cited
- → Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias(2016)66 cited
- → Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma(2017)61 cited